Showing 1 - 5 results of 5 for search 'Yanchun Meng', query time: 0.02s Refine Results
  1. 1
    Retraction Note: MicroRNA-143 targets MAPK3 to regulate the proliferation and bone metastasis of human breast cancer cells

    Retraction Note: MicroRNA-143 targets MAPK3 to regulate the proliferation and bone metastasis of human breast cancer cells by Yiqun Du, Jian Zhang, Yanchun Meng, Mingzhu Huang, Wangjun Yan, Zhiqiang Wu

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Results and exploratory biomarker analyses of a phase II study CHANGEABLE: combination of HX008 and niraparib in GErm-line-mutAted metastatic breast cancer

    Results and exploratory biomarker analyses of a phase II study CHANGEABLE: combination of HX008 and niraparib in GErm-line-mutAted metastatic breast cancer by Yizi Jin, Yiqun Du, Yanchun Meng, Xuchen Shao, Xiaojun Liu, Yuxin Mu, Yun Liu, Zhen Hu, Jian Zhang

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Enhanced integrated therapy for breast cancer employing Honokiol-loaded mesoporous polydopamine nanoparticles in conjunction with photothermal effects and low-dose metformin

    Enhanced integrated therapy for breast cancer employing Honokiol-loaded mesoporous polydopamine nanoparticles in conjunction with photothermal effects and low-dose metformin by Qianqian Du, Qianfan Zhang, Jialing Li, Xiaofei Wang, Xiangyu Gao, Guangyuan Tan, Qian Feng, Jigang Li, Yanchun Meng, Yongsheng Yu

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.

    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial. by Jian Zhang, Yanchun Meng, Biyun Wang, Xinhong Wu, Hongmei Zheng, Jing Hu, Wei Liu, Wenyan Chen, Leiping Wang, Jun Cao, Zhonghua Tao, Ting Li, Sujie Ni, Zhengyan Yu, Lichun Sun, Yun Wang, Qiang Peng, Song Wang, Xin Hu, Jianfei Wang, Yijia Wu, Xichun Hu

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial

    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial by Jian Zhang, Yanchun Meng, Biyun Wang, Xinhong Wu, Hongmei Zheng, Jing Hu, Wei Liu, Wenyan Chen, Leiping Wang, Jun Cao, Zhonghua Tao, Ting Li, Sujie Ni, Zhengyan Yu, Lichun Sun, Yun Wang, Qiang Peng, Song Wang, Xin Hu, Jianfei Wang, Yijia Wu, Xichun Hu

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: